Here come the mobile labs. From the Wall Street Journal.

New Post Public Reply Private Reply Replies (0) Message Board
freegriff
657
Here come the mobile labs. From the Wall Street Journal. Big time.
By Anne Kadet
March 16, 2021 10:00 am ET

I was surprised recently to spot a new business in my Brooklyn neighborhood. “COVID-19 RAPID TESTING” the sign trumpeted. “SAME DAY RESULTS.” It was a storefront dedicated entirely to coronavirus tests. This was puzzling. Why now? Aren’t we all getting vaccinated?

But this was no anomaly. For better or worse, entrepreneurs say Covid-19 testing will be a profitable business in New York City for a long time to come. Their ventures are ambitious and, in some cases, surprisingly imaginative.

Manhattan-based Todos Medical mainly develops cancer-detection tests. But next month it will launch what it believes to be the city’s first mobile Covid-testing labs. CEO Gerald Commissiong envisions the company’s 20-foot container boxes parked outside Madison Square Garden serving fans who need a fast lab result to attend a Knicks game.

The company has so far spent $1.2 million constructing two portable lab facilities and has 10 more in production. If demand meets expectations, the investment could pay off fast. Mr. Commissiong says the units can process 3,000 to 5,000 tests a day, charging $200 a pop. “We think there is going to be big demand in Manhattan with Broadway opening up,” he says.

Bracha Banayan, CEO of Brooklyn-based IVDrips, a service providing at-home IV hydration and nutrient treatments to combat maladies such as migraines and hangovers, says Covid testing accounts for 40% to 50% of her business, which expanded last year from 15 to 25 nurses.

It specializes in rush jobs. Nurses collect swabs from clients in their homes and offices, and speed them to a lab for testing. IVDrips has negotiated “VIP contracts” with four labs around New York City to get priority processing.

Customers pay $200 to $500 to get results in as little as eight hours, and wealthy clients planning last-minute travel are happy to pay. “They don’t blink an eye at those numbers,” Ms. Banayan says.

The dedicated Covid-testing storefront strategy also is attracting the venturesome. Maverick Health CEO and co-founder Ezra Gontownik, a healthcare entrepreneur, opened three such operations in downtown Manhattan last month and plans eight more uptown. He has partnered with a Financial District hotel to set up shop off the lobby, offering rapid-result tests to people attending weddings and other functions.

Like many of these startups, Maverick Health doesn’t take insurance for the tests, which start at $99, but they provide a wait-free experience and fast turnaround, Mr. Gontownik says.

The New York City market is appealing because it was hit hard by Covid-19 and it has a dense population, entrepreneurs say. People won’t travel far for a test and the business depends largely on high-visibility locations that advertise to passersby, say Maxo Oehme and Felix Huettenbach, co-founders of Sameday Health, a national Covid-testing business that launched in September and opened three locations in Manhattan and Brooklyn this year.

But how many providers do we need? The New York metro area offers one Covid-19 testing site for every 15,000 people—a rate double that of San Francisco and Boston, according to Castlight Health, a healthcare navigation company that provides directories and other services to employers.

The number of sites in the five boroughs, meanwhile, rose from 452 in September to 616 at the end of February, according to Castlight. While the count has decreased since peaking in December, that’s largely due to the mobile-testing facilities that were activated for the holidays being taken off the streets.


A medical worker stood outside a mobile Covid-19 testing lab in Brooklyn in January.
PHOTO: SPENCER PLATT/GETTY IMAGES
Dr. Talya Schwartz, president and CEO of MetroPlusHealth, the health insurance plan of NYC Health + Hospitals, says that while there was a testing-capacity shortage in the past, that hasn’t been the case for several months. “There is now sufficient capacity in the city to meet demand,” she says.

Nationwide, testing demand has dropped 46% since the start of the year, according to healthcare appointment booking platform Solv.

So why do new sites keep popping up? In some cases, the operations serve as a sort of Trojan horse—a location can offer Covid-19 testing now and additional services later.

It’s difficult to gain a foothold in New York City, but the pandemic created an opportunity for those bold enough to act fast. “We could never build a company this quick in normal times,” says Pavel Stuchlik, a Houston entrepreneur who is opening a three-story Covid-testing center on West 34th Street in Manhattan.

By the time test demand dwindles, he expects the startup he co-founded, Wellness 4 Humanity, to be well-established in New York City, serving corporate clients and individuals with a range of preventive and wellness-care services.

Others expect demand to last for a long while as the still unvaccinated see the city opening up and want to join the party.

Until the pandemic hit, Brooklyn-based Paradocs was best known for providing first aid and EMT services at some of the city’s biggest music festivals. Since then, it’s been administering up to 10,000 Covid-19 tests a week at construction sites and TV shoots. “Ninety-five percent of our business has been Covid testing,” says founder and CEO Alex Pollak. “We’ve done way more than we’ve ever done, revenue-wise.”

Now he’s getting requests to provide testing at concerts and music festivals that will require either proof of vaccination or a negative test result. “The big events are coming back in September,” he says.

But Mr. Pollak would rather not see the testing business booming. “If you told me tomorrow we don’t have to do any more Covid testing,” he says, “I’d be the happiest person ever.”

https://www.wsj.com/articles/entrepreneurs-ar...1615903201

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Network API Market by 2030

Updated Category News Views 125

Network API Market Overview As technology evolves, the demand for Network APIs is accelerating, and projections show the market will grow from USD 1.96 billion to an impressive USD 6.13 billion by 2030, reflecting a compound annual growth rate (CAGR) of 25.7% during the forecast period. This surge signifies a shift in how businesses leverage APIs to enhance connectivity...

Continue Reading
Quebec City Real Estate Market Sees Strong Activity Surge

Updated Category News Views 179

Quebec City Real Estate Market Activity in August As summer comes to a close, the residential real estate market in Quebec City is experiencing notable activity, achieving the second highest sales levels in 25 years for this month. This trend highlights the remarkable resilience and ongoing demand in a market that continues to change. Sales Data Overview In August, the...

Continue Reading
Understanding Market Trends: Income Strategies with IQQQ ETF

Updated Category News Views 151

Navigating the Current Tech Market Dynamics This year, the Nasdaq Composite index has outperformed other major indices, showing a solid increase of more than 21%. This surge in technology stocks has, however, been volatile, with the index recently experiencing a dip of roughly 2%. Concerns around a potential bubble in artificial intelligence have contributed to this...

Continue Reading
Boussard & Gavaudan Holding Limited: Latest NAV Update

Updated Category News Views 272

Boussard & Gavaudan Holding Limited Overview Boussard & Gavaudan Holding Limited is a well-known closed-ended investment company recognized within the finance industry for its effective management strategies. This article provides recent updates on the company's net asset value (NAV) and market activities. Estimated NAV Information The Directors of Boussard & Gavaudan...

Continue Reading
Currency Insights: Dollar and Yen Dynamics Amid Changes

Updated Category News Views 153

Current Trends in Currency Markets The US dollar is maintaining its strength as holiday trading continues with low volumes, while US Treasury yields are gradually rising. Although the dollar remains resilient against various currencies, it has shown some weakness against the Japanese yen and Canadian dollar lately. Markets are keenly observing the impact of potential...

Continue Reading